99 research outputs found
Lifestyle and cardiovascular mortality in menopausal women: a population-based cohort study
Introduction and objectives: There are models for cardiovascular risk prediction in the general population,
but the prediction of risk in postmenopausal women has not been specifically studied. This study aimed
to determine the association of lifestyle habits and chronic diseases with cardiovascular risk in menopausal women, as well as to build a risk scale.
Methods: Retrospective population-based cohort study using data from the 2011 National Health Survey
of Spain as a data source, Women 50 years were included. The characteristics that best defined the life
habits of the study women were collected, as well as their health status and self-reported medical
history at the time of the survey. Follow-up data on all-cause mortality were obtained from participants
from 2011 to 2017.
Results: A total of 5953 women 50 years of age were included, with a mean age of 66.4 11.4 years. The
incidence of cardiovascular mortality in the follow-up period was 4%. Vegetable consumption less than
1 time/week (HR, 1.758), smoking (HR, 1.816) or excess hours of sleep ( 9 h/day, HR, 1.809), or o have main
daily activity sitting most of the time (HR, 2.757) were related to cardiovascular mortality. The predictive
model presents an honest C-index in test sample of 0.8407 (95%CI, 0.8025-0.8789).
Conclusions: Life habits such as the consumption of vegetables, daily main activity, sleeping hours or
smoking are risk factors for cardiovascular mortality of great relevance among menopausal women. A
simple 6-year self-reported risk scale with high predictive capacity is provide
Risk factors for major adverse cardiovascular events in postmenopausal women: UK Biobank prospective cohort study
Background and aims
Cardiovascular risk increases during menopause, so the medical and scientific community should consider women's specific risk factors to prevent cardiovascular disease. This study aims to assess the risk factors for the incidence of major adverse cardiovascular events (MACE) exclusive to postmenopausal women.
Methods
We conducted a prospective cohort study in postmenopausal women aged 40 years and older, who were included in the UK Biobank cohort between 2006 and 2010 and followed to 2021 (12 years). A total of 156,787 women were followed for a median of 12.5 years (nearly 2 million person-years), and MACE risk was assessed using Fine-Gray competing risk models.
Results
The cumulative incidence of cardiovascular morbidity and mortality was 1.2% (0.97 cases per 1000 women-years). Not having taken birth control pills, not having children, and early menarche (≤12 years) were independently associated with cardiovascular morbidity and mortality.
Conclusions
Risk factors for cardiovascular disease that are specific to women include early menarche, not having taken oral contraceptives, and reproductive history, and this relationship is independent of classic cardiovascular risk factors
Effectiveness and Efficiency of Drug Eluting Stents
Coronary artery disease (CAD), also known as ischemic heart disease (IHD) and coronary
heart disease (CHD), is caused by the narrowing (stenosis) of one or more coronary arteries,
due to atherosclerosis, restricting blood flow and reducing the supply of oxygen to the heart
muscle. Transient shortages in blood flow and oxygen lead to angina pectoris and chest
pain, which may radiate to the left shoulder, arms, neck, back or jaw. Stable angina
symptoms do not tend to progress in intensity over time. More seriously, the rupturing of
an atherosclerotic plaque (causing a thrombotic occlusion) and stenosis of the vessel can
result in acute myocardial infarction (AMI) due to a critical reduction in the blood supply to
the heart muscle (myocardial ischemia). High levels of morbidity and mortality associated
with this infarction are a consequence of ischemia. It is vital to promptly re-establish
coronary blood flow after an infarction, because sustained ischemic damages and injuries to
the heart muscle may lead to sudden death or heart failure. In addition to infarction, acute
symptomatic manifestations of ischemic heart disease include unstable angina, and less
common conditions such as cardiogenic shock and sudden death (Thygesen, 2007)..
Impact of operatoŕs experience on peri-procedural outcomes with Watchman FLX: Insights from the FLX-SPA registry
Background: The Watchman FLX is a device upgrade of the Watchman 2.5 that incorporates several design enhancements intended to simplify left atrial appendage occlusion (LAAO) and improve procedural outcomes. This study compares peri-procedural results of LAAO with Watchman FLX (Boston Scientific, Marlborough, Massachusetts) in centers with varying degrees of experience with the Watchman 2.5 and Watchman FLX. Methods: Prospective, multicenter, 'real-world' registry including consecutive patients undergoing LAAO with the Watchman FLX at 26 Spanish sites (FLX-SPA registry). Implanting centers were classified according to the center's prior experience with the Watchman 2.5. A further division of centers according to whether or not they had performed ≤ 10 or > 10Watchman FLX implants was prespecified at the beginning of the study. Procedural outcomes of institutions stratified according to their experience with the Watchman 2.5 and FLX devices were compared. Results: 359 patients [mean age 75.5 (SD8.1), CHA2DS2-VASc 4.4 (SD1.4), HAS-BLED 3.8(SD0.9)] were included. Global success rate was 98.6%, successful LAAO with the first selected device size was achieved in 95.5% patients and the device was implanted at first attempt in 78.6% cases. There were only 9(2.5%) major peri-procedural complications. No differences in efficacy or safety results according to the centeŕs previous experience with Watchman 2.5 and procedural volume with Watchman FLX existed. Conclusions: The Watchman FLX attains high procedural success rates with complete LAA sealing in unselected, real-world patients, along with a low incidence of peri-procedural complications, regardless of operatoŕs experience with its previous device iteration or the number of Watchman FLX devices implanted
Antithrombotic Therapy in Elderly Patients with Acute Coronary Syndromes
The treatment of acute coronary syndrome (ACS) in elderly patients continues to be a challenge because of the characteS.G.B.ristics of this population and the lack of data and specific recommendations. This review summarizes the current evidence about critical points of oral antithrombotic therapy in elderly patients. To this end, we discuss the peculiarities and differences reported referring to dual antiplatelet therapy (DAPT) in ACS management in elderly patients and what might be the best option considering these population characteristics. Furthermore, we analyze antithrombotic strategies in patients with atrial fibrillation (AF), with a particular focus on those cases that also present coronary artery disease (CAD). It is imperative to deepen our knowledge regarding the management of these challenging patients through real-world data and specifically designed geriatric studies to help resolve the questions remaining in their disease management
Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure.
Left atrial appendage (LAA) thrombus has heretofore been considered a contraindication to percutaneous LAA closure (LAAC). Data regarding its management are very limited. The aim of this study was to analyse the medical and invasive treatment of patients referred for LAAC in the presence of LAA thrombus. This multicentre observational registry included 126 consecutive patients referred for LAAC with LAA thrombus on preprocedural imaging. Treatment strategies included intensification of antithrombotic therapy (IAT) or direct LAAC. The primary and secondary endpoints were a composite of bleeding, stroke and death at 18 months, and procedural success, respectively. IAT was the preferred strategy in 57.9% of patients, with total thrombus resolution observed in 60.3% and 75.3% after initial and subsequent IAT, respectively. Bleeding complications and stroke during IAT occurred in 9.6% and 2.9%, respectively, compared with 3.8% bleeding and no embolic events in the direct LAAC group before the procedure. Procedural success was 90.5% (96.2% vs 86.3% in direct LAAC and IAT group, respectively, p=0.072), without cases of in-hospital thromboembolic complications. The primary endpoint occurred in 29.3% and device-related thrombosis was found in 12.8%, without significant difference according to treatment strategy. Bleeding complications at 18 months occurred in 22.5% vs 10.5% in the IAT and direct LAAC group, respectively (p=0.102). In the presence of LAA thrombus, IAT was the initial management strategy in half of our cohort, with initial thrombus resolution in 60% of these, but with a relatively high bleeding rate (~10%). Direct LAAC was feasible, with high procedural success and absence of periprocedural embolic complications. However, a high rate of device-related thrombosis was detected during follow-up
Post-Franco Theatre
In the multiple realms and layers that comprise the contemporary Spanish theatrical landscape, “crisis” would seem to be the word that most often lingers in the air, as though it were a common mantra, ready to roll off the tongue of so many theatre professionals with such enormous ease, and even enthusiasm, that one is prompted to wonder whether it might indeed be a miracle that the contemporary technological revolution – coupled with perpetual quandaries concerning public and private funding for the arts – had not by now brought an end to the evolution of the oldest of live arts, or, at the very least, an end to drama as we know it
Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-up
Repercusión ecocardiográfica de la hipertensión arterial en el anciano
Tesis doctoral inédita leída en la Universidad Autónoma de Madrid, Facultad de Medicina, Departamento de Medicina. Fecha de lectura: 1 de Febrero de 1999
Antithrombotic therapy and bleeding risk in atrial fibrillation. Fewer unanswered questions
- …